![Wu-Sung Ki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Wu-Sung Ki
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CELLTRION, INC. | Director/Miembro de la Junta | 24/04/2007 | - |
Director Ejecutivo | 20/03/2015 | - | |
Corporate Officer/Principal | 24/04/2007 | - |
Historial de carrera de Wu-Sung Ki
Antiguos cargos conocidos de Wu-Sung Ki.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CELLTRION HEALTHCARE CO., LTD. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Celltrion Skincure Co., Ltd.
![]() Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Director/Miembro de la Junta | - | 15/10/2014 |
Corporate Officer/Principal | - | - |
Estadísticas
Internacional
Corea del Sur | 4 |
Operativa
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CELLTRION, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Celltrion Skincure Co., Ltd.
![]() Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Healthcare Co., Ltd.
![]() Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Wu-Sung Ki
- Experiencia